PACS Group, Inc. (NYSE:PACS – Get Free Report) CEO Jason Murray sold 1,620 shares of the business’s stock in a transaction that occurred on Monday, October 19th. The stock was sold at an average price of $47.57, for a total transaction of $77,063.40. Following the completion of the sale, the chief executive officer owned 54,314,900 shares of the company’s stock, valued at approximately $2,583,759,793. The trade was a 0.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Jason Hulse Murray also recently made the following trade(s):
- On Wednesday, October 21st, Jason Murray sold 6,610 shares of PACS Group stock. The shares were sold at an average price of $47.62, for a total transaction of $314,768.20.
- On Tuesday, October 20th, Jason Murray sold 37,477 shares of PACS Group stock. The shares were sold at an average price of $47.65, for a total transaction of $1,785,779.05.
- On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The stock was sold at an average price of $47.61, for a total transaction of $402,875.82.
- On Thursday, October 15th, Jason Murray sold 110,035 shares of PACS Group stock. The stock was sold at an average price of $47.27, for a total transaction of $5,201,354.45.
- On Wednesday, October 14th, Jason Murray sold 232 shares of PACS Group stock. The stock was sold at an average price of $45.00, for a total transaction of $10,440.00.
- On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The shares were sold at an average price of $42.48, for a total transaction of $30,458.16.
- On Tuesday, October 6th, Jason Murray sold 35,975 shares of PACS Group stock. The shares were sold at an average price of $43.09, for a total transaction of $1,550,162.75.
- On Monday, October 5th, Jason Murray sold 24,224 shares of PACS Group stock. The shares were sold at an average price of $42.66, for a total value of $1,033,395.84.
- On Friday, October 2nd, Jason Murray sold 26,052 shares of PACS Group stock. The shares were sold at an average price of $42.51, for a total value of $1,107,470.52.
- On Thursday, October 1st, Jason Murray sold 33,032 shares of PACS Group stock. The stock was sold at an average price of $41.13, for a total value of $1,358,606.16.
PACS Group Trading Down 2.2%
Shares of PACS traded down $1.03 during trading hours on Wednesday, hitting $46.69. The company had a trading volume of 648,381 shares, compared to its average volume of 892,400. PACS Group, Inc. has a 52-week low of $10.31 and a 52-week high of $49.49. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.21. The stock’s 50 day moving average price is $43.58 and its 200 day moving average price is $40.70. The firm has a market cap of $7.39 billion, a P/E ratio of 27.14, a P/E/G ratio of 1.43 and a beta of -0.08.
PACS Group (NYSE:PACS – Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.09. The company had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.41 billion. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. On average, research analysts predict that PACS Group, Inc. will post 2.13 EPS for the current year.
Wall Street Analyst Weigh In
Several brokerages have weighed in on PACS. Royal Bank Of Canada boosted their price objective on PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a research report on Thursday, August 6th. Oppenheimer increased their price objective on PACS Group from $48.00 to $57.00 and gave the company an “outperform” rating in a research note on Monday, August 10th. Truist Financial set a $62.00 target price on shares of PACS Group in a report on Wednesday, September 2nd. Zacks Research cut shares of PACS Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 9th. Finally, Weiss Ratings raised shares of PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, October 8th. Five analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $58.80.
Check Out Our Latest Stock Analysis on PACS
Hedge Funds Weigh In On PACS Group
A number of hedge funds have recently modified their holdings of PACS. Dimensional Fund Advisors LP raised its stake in shares of PACS Group by 370.2% during the first quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company’s stock valued at $25,051,000 after acquiring an additional 614,250 shares during the last quarter. Bank of New York Mellon Corp purchased a new stake in shares of PACS Group during the second quarter worth about $8,196,000. Principal Financial Group Inc. purchased a new stake in shares of PACS Group during the first quarter worth about $3,171,000. Arrowstreet Capital Limited Partnership boosted its holdings in shares of PACS Group by 44.6% during the first quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company’s stock worth $9,274,000 after purchasing an additional 89,067 shares during the period. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in shares of PACS Group in the second quarter worth about $1,893,000.
About PACS Group
PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.
The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.
Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.
Featured Articles
- Five stocks we like better than PACS Group
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
